Gen Incode
Oxford, GB · 2 known investors
GENinCode develops genetic and clinical testing products for cardiovascular disease and familial hypercholesterolemia, providing risk assessment and prediction to help physicians stratify patients and select treatment pathways. It works with healthcare providers including the NHS in the UK.
Investors · 2
Frequently asked questions
- What does Gen Incode do?
- GENinCode develops genetic and clinical testing products for cardiovascular disease and familial hypercholesterolemia, providing risk assessment and prediction to help physicians stratify patients and select treatment pathways. It works with healthcare providers including the NHS in the UK.
- Who are Gen Incode's investors?
- Gen Incode's investors include Maven Capital Partners, Cambridge Innovation Capital.
- Where is Gen Incode headquartered?
- Gen Incode is headquartered in Oxford, GB.